Alistair Macdonald
CIK 1624073 · Chief Executive Officer · last filed 2022-03-04
Alistair Macdonald is a Chief Executive Officer who has filed 55 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for SYNH, was dated Mar 4, 2022. Across all open-market trades the lifetime net is −$30.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $96.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$96.1K
2
55
-$30.06M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Syneos Health, Inc. (SYNH) Delisted | Chief Executive Officer | 254,892 | $42.98 | $10.96M | -$15.12M | 35 | 2022-03-04 |
| INCR | Chief Executive Officer | 99,453 | $0.97 | $96.1K | -$14.94M | 20 | 2017-09-19 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-04 | Syneos Health, Inc. (SYNH) Delisted | Mixed | +27,055 | -$2.16M | EDGAR |
| 2022-01-20 | Syneos Health, Inc. (SYNH) Delisted | Mixed | +15,470 | -$1.29M | EDGAR |
| 2022-01-12 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −10,154 | -$951.3K | EDGAR |
| 2021-08-04 | Syneos Health, Inc. (SYNH) Delisted | Mixed | −4,710 | -$2.03M | EDGAR |
| 2021-06-03 | Syneos Health, Inc. (SYNH) Delisted | Mixed | — | -$221.6K | EDGAR |
| 2021-04-12 | Syneos Health, Inc. (SYNH) Delisted | Sell (S) | −14,039 | -$1.12M | EDGAR |
| 2021-04-05 | Syneos Health, Inc. (SYNH) Delisted | Mixed | — | -$652.2K | EDGAR |
| 2021-03-04 | Syneos Health, Inc. (SYNH) Delisted | Mixed | +16,916 | -$2.40M | EDGAR |
| 2021-02-18 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −12,450 | -$978.4K | EDGAR |
| 2021-02-03 | Syneos Health, Inc. (SYNH) Delisted | Sell (S) | −64,497 | -$4.88M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.